SPECIALTY CARE 
Supporting Patients During GLP-1 Receptor Agonist Shortages
Updated: 12/01/23
Due to the glycemic, weight loss, and cardiovascular benefits of GLP-1 receptor agonists, many of these medications are experiencing short-term shortages. Here are some tips for supporting patients during medication shortages.
This one-page guide, developed by Jonathan Gabison, MD (first author), Lauren Oshman, MD, MPH, FAACP and Heidi Diez, PharmD, provides dosing and titration guidelines for switching between GLP-1 RA/GIPs during the national shortage in the United States, as well as functional tips for navigating medication shortages.
Patients: Please leave feedback about this tool (counts towards PO-Level VBR requirement)Tags: For Providers, Point-of-care, Created By MCT2D
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross and Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.